Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
AstraZeneca Pharma India Limited ( (IN:ASTRAZEN) ) has shared an announcement.
AstraZeneca Pharma India Limited has submitted a compliance certificate to the stock exchanges, confirming adherence to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This announcement underscores the company’s commitment to regulatory compliance, which is crucial for maintaining investor trust and ensuring smooth operations within the financial markets.
More about AstraZeneca Pharma India Limited
AstraZeneca Pharma India Limited operates in the pharmaceutical industry, focusing on the development and distribution of prescription medicines. The company is part of the global AstraZeneca group, which is known for its innovative treatments in areas such as oncology, cardiovascular, renal, and respiratory diseases.
Average Trading Volume: 3,633
Current Market Cap: 230.9B INR
For an in-depth examination of ASTRAZEN stock, go to TipRanks’ Overview page.